1
|
Günzel D and Yu AS: Claudins and the
modulation of tight junction permeability. Physiol Rev. 93:525–569.
2013. View Article : Google Scholar : PubMed/NCBI
|
2
|
Lu S, Singh K, Mangray S, Tavares R, Noble
L, Resnick MB and Yakirevich E: Claudin expression in high-grade
invasive ductal carcinoma of the breast: Correlation with the
molecular subtype. Mod Pathol. 26:485–495. 2013. View Article : Google Scholar : PubMed/NCBI
|
3
|
Mineta K, Yamamoto Y, Yamazaki Y, Tanaka
H, Tada Y, Saito K, Tamura A, Igarashi M, Endo T, Takeuchi K, et
al: Predicted expansion of the claudin multigene family. FEBS Lett.
585:606–612. 2011. View Article : Google Scholar : PubMed/NCBI
|
4
|
Kwon MJ: Emerging roles of claudins in
human cancer. Int J Mol Sci. 14:18148–18180. 2013. View Article : Google Scholar : PubMed/NCBI
|
5
|
Li X, Li Y, Qiu H and Wang Y:
Downregulation of claudin 7 potentiates cellular proliferation and
invasion in endometrial cancer. Oncol Lett. 6:101–105.
2013.PubMed/NCBI
|
6
|
Rendon-Huerta EP, Torres-Martínez AC and
Montaño L: CLDN6 (claudin 6). Atlas Genet Cytogenet Oncol Haematol.
17:396–399. 2013.
|
7
|
Zavala-Zendejas VE, Torres-Martinez AC,
Salas-Morales B, Fortoul TI, Montaño LF and Rendon-Huerta EP:
Claudin-6, 7, or 9 overexpression in the human gastric
adenocarcinoma cell line AGS increases its invasiveness, migration,
and proliferation rate. Cancer Invest. 29:1–11. 2011. View Article : Google Scholar : PubMed/NCBI
|
8
|
Wang L, Xue Y, Shen Y, Li W, Cheng Y, Yan
X, Shi W, Wang J, Gong Z, Yang G, et al: Claudin 6: A novel surface
marker for characterizing mouse pluripotent stem cells. Cell Res.
22:1082–1085. 2012. View Article : Google Scholar : PubMed/NCBI
|
9
|
Wang Q, Zhang Y, Zhang T, Han ZG and Shan
L: Low claudin-6 expression correlates with poor prognosis in
patients with non-small cell lung cancer. Onco Targets Ther.
8:1971–1977. 2015.PubMed/NCBI
|
10
|
Xu X, Jin H, Liu Y, Liu L, Wu Q, Guo Y, Yu
L, Liu Z, Zhang T, Zhang X, et al: The expression patterns and
correlations of claudin-6, methy-CpG binding protein 2, DNA
methyltransferase 1, histone deacetylase 1, acetyl-histone H3 and
acetyl-histone H4 and their clinicopathological significance in
breast invasive ductal carcinomas. Diagn Pathol. 7:332012.
View Article : Google Scholar : PubMed/NCBI
|
11
|
Ren Y, Wu Q, Liu Y, Xu X and Quan C: Gene
silencing of claudin-6 enhances cell proliferation and migration
accompanied with increased MMP-2 activity via p38 MAPK signaling
pathway in human breast epithelium cell line HBL-100. Mol Med Rep.
8:1505–1510. 2013.PubMed/NCBI
|
12
|
Zhang X, Ruan Y, Li Y, Lin D, Liu Z and
Quan C: Expression of apoptosis signal-regulating kinase 1 is
associated with tight junction protein claudin-6 in cervical
carcinoma. Int J Clin Exp Pathol. 8:55352015.PubMed/NCBI
|
13
|
Luscombe NM, Greenbaum D and Gerstein M:
What is bioinformatics? A proposed definition and overview of the
field. Methods Inf Med. 40:346–358. 2001.PubMed/NCBI
|
14
|
Ilzins OA, Isea R and Hoebeke J III: Can
bioinformatics be considered as an experimental biological science?
Open Sci J Biosci Bioeng. 2:60–62. 2015.
|
15
|
Isea R: The present-day meaning of the
word bioinformatics. Glob J Adv Res. 2:70–73. 2015.
|
16
|
Eck RV and Dayhoff MO: Evolution of the
structure of ferredoxin based on living relics of primitive amino
acid sequences. Science. 152:363–366. 1966. View Article : Google Scholar : PubMed/NCBI
|
17
|
Koval M: Differential pathways of claudin
oligomerization and integration into tight junctions. Tissue
Barriers. 1:e245182013. View Article : Google Scholar : PubMed/NCBI
|
18
|
Anelli T and Sitia R: Protein quality
control in the early secretory pathway. EMBO J. 27:315–327. 2008.
View Article : Google Scholar : PubMed/NCBI
|
19
|
Piontek J, Winkler L, Wolburg H, Müller
SL, Zuleger N, Piehl C, Wiesner B, Krause G and Blasig IE:
Formation of tight junction: Determinants of homophilic interaction
between classic claudins. FASEB J. 22:146–158. 2008. View Article : Google Scholar : PubMed/NCBI
|
20
|
Hou J, Renigunta A, Konrad M, Gomes AS,
Schneeberger EE, Paul DL, Waldegger S and Goodenough DA: Claudin-16
and claudin-19 interact and form a cation-selective tight junction
complex. J Clin Invest. 118:619–628. 2008.PubMed/NCBI
|
21
|
Overgaard CE, Daugherty BL, Mitchell LA
and Koval M: Claudins: control of barrier function and regulation
in response to oxidant stress. Antioxid Redox Signal. 15:1179–1193.
2011. View Article : Google Scholar : PubMed/NCBI
|
22
|
Morita K, Furuse M, Fujimoto K and Tsukita
S: Claudin multigene family encoding four-transmembrane domain
protein components of tight junction strands. Proc Natl Acad Sci
USA. 96:511–516. 1999. View Article : Google Scholar : PubMed/NCBI
|
23
|
Guo Y, Xu X, Liu Z, Zhang T, Zhang X, Wang
L, Wang M, Liu Y, Lu Y, Liu YA, et al: Apoptosis signal-regulating
kinase 1 is associated with the effect of claudin-6 in breast
cancer. Diagn Pathol. 7:1112012. View Article : Google Scholar : PubMed/NCBI
|
24
|
Zhang X, Ruan Y, Li Y, Lin D and Quan C:
Tight junction protein claudin-6 inhibits growth and induces the
apoptosis of cervical carcinoma cells in vitro and in vivo. Med
Oncol. 32:1482015. View Article : Google Scholar : PubMed/NCBI
|
25
|
Zheng A, Yuan F, Li Y, Zhu F, Hou P, Li J,
Song X, Ding M and Deng H: Claudin-6 and claudin-9 function as
additional coreceptors for hepatitis C virus. J Virol.
81:12465–12471. 2007. View Article : Google Scholar : PubMed/NCBI
|
26
|
Wu Q, Wu X-Y, Zhang H-Y, Liu Y-F, Ren Y,
Qu S-S, Quan C-S and Li Y-L: Expression of tight junctions protein
claudin-6 in breast cancer tissues and cell lines and its
relationship with metastasis of breast cancer. J Jilin Univ Med
Edit. 34:274–279. 2008.(In Chinese).
|
27
|
Lin Z, Zhang X, Liu Z, Liu Q, Wang L, Lu
Y, Liu Y, Wang M, Yang M, Jin X, et al: The distinct expression
patterns of claudin-2, −6, and −11 between human gastric neoplasms
and adjacent non-neoplastic tissues. Diagn Pathol. 8:1332013.
View Article : Google Scholar : PubMed/NCBI
|
28
|
Wu Q, Liu Y, Ren Y, Xu X, Yu L, Li Y and
Quan C: Tight junction protein, claudin-6, downregulates the
malignant phenotype of breast carcinoma. Eur J Cancer Prev.
19:186–194. 2010. View Article : Google Scholar : PubMed/NCBI
|
29
|
Liu Y, Jin X, Li Y, Ruan Y, Lu Y, Yang M,
Lin D, Song P, Guo Y, Zhao S, et al: DNA methylation of claudin-6
promotes breast cancer cell migration and invasion by recruiting
MeCP2 and deacetylating H3Ac and H4AcJ. J Exp Clin Cancer Res.
35:1202016. View Article : Google Scholar : PubMed/NCBI
|
30
|
Ohazama A and Sharpe PT: Expression of
claudins in murine tooth development. Dev Dyn. 236:290–294. 2007.
View Article : Google Scholar : PubMed/NCBI
|
31
|
Osanai M, Murata M, Chiba H, Kojima T and
Sawada N: Epigenetic silencing of claudin-6 promotes
anchorage-independent growth of breast carcinoma cells. Cancer Sci.
98:1557–1562. 2007. View Article : Google Scholar : PubMed/NCBI
|
32
|
Ribeiro A, Archer A, Le Beyec J, Cattin
AL, Saint-Just S, Pinçon-Raymond M, Chambaz J, Lacasa M and Cardot
P: Hepatic nuclear factor-4, a key transcription factor at the
crossroads between architecture and function of epithelia. Recent
Pat Endocr Metab Immune Drug Discov. 1:166–175. 2007. View Article : Google Scholar
|
33
|
Hui PJH: Small proline rich protein-2
expression and regulation in the Caco-2 model of intestinal
epithelial differentiation along the crypt-villus axis. QSPACE
Kingston, Ontario, Canada: Queen's University; 2008, http://hdl.handle.net/1974/1183
|
34
|
Nishikiori N, Sawada N and Ohguro H:
Prevention of murine experimental corneal trauma by epigenetic
events regulating claudin 6 and claudin 9. Jpn J Ophthalmol.
52:195–203. 2008. View Article : Google Scholar : PubMed/NCBI
|
35
|
Lal-Nag M, Battis M, Santin A and Morin P:
Claudin-6: A novel receptor for CPE-mediated cytotoxicity in
ovarian cancer. Oncogenesis. 1:e332012. View Article : Google Scholar : PubMed/NCBI
|
36
|
Guo Y, Lin D, Zhang M, Zhang X, Li Y, Yang
R, Lu Y, Jin X, Yang M, Wang M, et al: CLDN6-induced apoptosis via
regulating ASK1-p38/JNK signaling in breast cancer MCF-7 cells. Int
J Oncol. 48:2435–2444. 2016.PubMed/NCBI
|